In a single primary research, PecFent was demonstrated to generally be more practical than placebo (a dummy remedy) at managing breakthrough cancer pain in 83 adults who were currently being treated with opioids. The principle measure of usefulness was the change from the severity of pain measured with the patients ranking their suffering on the sc